BSE filing, BSE: 544105. Summary written from the filing by ALFA Finder's alert engine.
Harshdeep Hortico Ltd: key numbers
- Share price
- ₹86.61
- Market cap
- ₹139.4 Cr
- Revenue (annual)
- ₹68.71 Cr
- Net profit (annual)
- ₹12.52 Cr
- P/E (TTM)
- 11.1×Sector 26.8×
- Promoter holding
- 72.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Harshdeep Hortico Ltd
All →Harshdeep Hortico Capital Structure Change
Counter Cyclical Investments PMS bought 19,500 Harshdeep Hortico shares open-market. Its stake rose from 5.39% to 5.51% under SAST Reg 29(2).
Harshdeep Hortico Promoter Buying
Promoter Hitesh Chunilal Shah acquired 1,500 equity shares of Harshdeep Hortico Ltd through a market purchase. His total stake increased slightly to 71.84%.
- Promoter stake change
- +0.01%
Harshdeep Hortico Capital Structure Change
Counter Cyclical Investments Private Limited acquired 18,000 shares of Harshdeep Hortico Limited via open market. This transaction increased the non-promoter group's holding from 5.28% to 5.39%.
Harshdeep Hortico Annual General Meeting
Harshdeep Hortico filed proceedings of its 4th AGM held on 17 Sep 2026. The meeting approved audited financials, director appointments, and a final dividend of Rs. 0.25 per share.
Harshdeep Hortico Capital Structure Change
Counter Cyclical Investments Private Limited acquired 18,000 shares of Harshdeep Hortico Limited from the open market, increasing its stake to 5.28%.
Harshdeep Hortico Capital Structure Change
Counter Cyclical Investments Private Limited acquired 21,000 shares of Harshdeep Hortico Limited in an open market purchase. This transaction increased its total stake to 5.16%.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.